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The effect of serum vitamin D normalization in preventing 
recurrences of benign paroxysmal positional vertigo:  
A case-control study 
 
Abstract 
Background: Benign paroxysmal positional vertigo (BPPV) is a condition with recurrent 
attacks in a significant proportion of patients. The present case- control study was 
conducted to assess the influence of serum vitamin D normalization on recurrent attacks of 
vitamin D deficient patients. 
Methods: Diagnosis of BPPV was made based on history and clinical examination and 
exclusion of other conditions. Serum 25-hydroxy vitamin D (25-OHD) was measured 
using ELISA method and a levels of < 20 ng/ml was considered a deficiency of vitamin D. 
Inclusion criteria were as follows: history of recurrent attacks and serum 25-
OHD<20.ng/ml. While the patients with history of trauma, surgery and chronic systemic 
diseases were excluded. The patients were classified into two groups: treatment and 
control, intermittently. Both groups received Epley rehabilitation therapy one session per 
week for 4 weeks but the treatment group received an additional supplement of 50.000 IU 
of vitamin D (cholecalciferol) weekly for two months to achieve serum 25-OHD ≥ 30 
ng/ml and the study patients were followed-up for 6 months. 
Results: Twenty-seven patients were allocated to each group. At baseline, serum 25-OHD 
was similar (10.7±2.3 vs 11.41±1.9, P=0.23). At month 2, serum 25-OHD in the treatment 
group increased significantly to ≥ 30 ng/ ml, whereas serum 25-OHD in the control group 
remained unchanged (34.2±3.3 vs 10.6 10.6±2.2 ng/ml, P=0.001). During the follow-up 
period, attacks of BPPV in the treatment group decreased significantly compared with the 
control group (14.8% vs 96.3% OR= 0.18, P=0.001).  
Conclusion: The findings of this study indicate that the normalization of serum vitamin D 
significantly reduces BPPV recurrences. 
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Vertigo, the chief complaint of vestibular involvement in association with other 
manifestations such as dizziness, disequilibrium, blurred vision is a cause of morbidity and 
psychological symptoms (1-3). Any of these symptoms may occur in about 70% of 
patients with benign paroxysmal positional vertigo (BPPV) and in cases with recurrent 
symptoms, quality of life will be affected significantly (4). In one study, over an average 
period of 47 months, the recurrence rate was 27% and half of the attacks occured in the 
first 6 months (5). BPPV is the most common vestibular disease involving 2.4 % of 
population over a lifetime. It is more prevalent in women especially in the sixth decades of 
age. Most cases of BPPV are idiopathic (6) with recurrent attacks in about 15% of patients. 
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In a follow-up study, 50% of patients with BPPV had 
recurrent attacks over 10 years after disease onset which was 
more common in women than in men and often occured 
during the first year after diagnosis (7).  
Diagnosis of BPPV is usually based on history and 
clinical examination and the mechanism of vertigo has been 
attributed to calcium debris within the posterior semicircular 
canal known as canalithiasis. Currently various types of 
vestibular rehabilitation therapy are used for treatment of 
BPPV.  
A review of 11 clinical trials compared the effectiveness 
of Epley maneuver with placebo or no treatment, the 
maneuver was safe and associated with recurrence rate of 
36% (8). In a prospective study, treatment with repositioning 
maneuver was effective in 88% of patients over 1 year 
follow up with 7.5% relapses (4).  
In another prospective study of canalith repositioning 
procedure, 91.3% recovered after 1 or 2 treatment sessions. 
Over the follow-up periods of 26 and 40 months, recurrences 
occurred in 26.3% and 50% respectively (9). Similarly, 90% 
of patients with BPVV responded to physical maneuver with 
a recurrence rate of 12% over 1.5 -year follow-up period 
(10). 
 Medical therapy is usually indicated for acute episodes 
of vertigo to suppress vestibular function and alleviate 
symptoms but in mild episodes of BPPV, medical treatment 
is not useful (2). These observations indicate that BPPV is a 
recurrent condition and prevention of recurrence rates 
requires identification and correction of responsible risk 
factors.  
A few studies have shown a correlation between serum 
vit D and recurrences of BPPV (11-13). It was shown that vit 
D deficiency and insufficiency are indepently associated 
with BPPV and increase the risk of BPPV attacks (12). On 
the other hand, the patients with recurrent attacks of vertigo 
have lower serum vit D than those without recurrences (13).  
Vit D deficiency is highly prevalent in the general 
population and is associated with the progression of many 
clinical conditions (14-18). In vit D deficient patients, 
correction of deficiency resulted in significant improvement 
on osteoarthritis knee pain, pulmonary function, and muscle 
strength (19). These observations suggest raising serum 
vitamin D level to normal condition. In one study, the 
recurrences of BPPV were improved after correction of vit D 
deficiency (11).  
Regarding the association of BPPV and vit D deficiency, 
normalization of vit D deficiency in patients with BPPV 
deserves further consideration. 
Data in this context are scarce and the present case- 
control study was conducted to assess the influence of serum 
vit D normalization on recurrent attacks of BPPV in vit D 
deficient patients.  
 
 
Methods 
The study population was selected consecutively 
according to inclusion criteria  among vit D deficient BPPV 
patients presented to Ayatollah Rouhani Hospital ENT 
clinics over 9 months period from April 2014 to December 
2014. Diagnosis of BPPV was made based on history and 
clinical examination and exclusion of other conditions. Vit D 
deficiency was confirmed by serum 25-hydroxyvitamin D 
(25-OHD) measurement using ELISA method. A level less 
than 20 ng/ml was considered a deficiency (18).  
All patients had history of at least two or more attacks of 
BPPV over 6 months prior to inclusion. Exclusion criteria 
were as follows: history of head and ear trauma, surgery or 
infectious diseases of the ear, maxillary sinuses and neck 
areas, chronic hematologic, renal, gastrointestinal, 
cardiovascular diseases, taking calcium supplements, vit D 
and drugs that affect vit D metabolism.  
 Data were collected through an interview, clinical 
examination, and laboratory tests. All patients received 
Epley rehabilitation therapy one time per week for 4 weeks. 
The study patients were intermittently allocated to treatment 
group (Epley therapy + supplemental vitamin D) or control 
group (Epley therapy alone).  
Serum vit D in all patients and controls was measured at 
baseline, month 1, month 2, and month 6. Treatment group 
received 50.000 IU cholecalciferol weekly for two months to 
raise serum 25-OHD up to 30 ng/ml or higher whereas; the 
control group received only rehabilitation therapy.  
The number of BPPV attacks in each group was recorded 
over six months follow-up period. In statistical analysis, the 
two groups were compared according to presence or absence 
of attacks of BPPV as well as the number of attacks. Chi 
square test with calculation of odds ratio (OR) was used for 
comparison of qualitative variables and student t-test was 
used for the comparison of quantitative variables.  SPSS 
software was used for statistical analysis. 
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Results 
A total of 54 vit D-deficient patients were recruited into 
this study. Characteristics of the patients and controls are 
presented in table 1. At baseline, the two groups were similar 
with regard to serum 25-OHD. After treatment with 
cholecalciferol serum 25-OHD was raised to normal level (> 
30 ng/ml) in the treatment group with mean value of 34.2 ± 
3.3 ng/ml at month 2 whereas, in the control group, the 
serum 25-OHD remained at deficient level of 10.6  ± 2.2 
ng/ml (P=0.001) (table 1). 
During the follow-up period attacks of BPPV, the 
treatment group was significantly lower than the control 
group (14.8% vs 96.3% OR= 0.18, P=0.001), indicating that 
supplemental vit D reduced the risk of recurrence by 82%.  
There was also no significant difference in recurrence 
rate between male and female patients (P=0.37) 
 
Table 1. Characteristics of 25-hydroxy vitamin D (25-
OHD) deficient patients¥ with benign paroxysmal 
positional vertigo treated with Epley rehabilitation 
manouevre with (treatment group) and without 
supplemental vitamin D (control group) 
 
Variables 
Mean±SD 
Control 
n=27 
Treatment 
n=27 
P-value 
Age, years 48.2±4.8 47.8±5.7  
Sex, females No (%) 14(51.9) 15.(55.6) 0.86 
Serum  25-OHD  status, ng/ml  
Baseline 10.7±2.3 11.41±1.9 0.23 
Month 1 10.6±2.2 19.37±3.3 0.001 
Month 2 10.6±2.2 34.2±3.3 0.001 
Month 6 11.1±2.3 35.5±2.9 0.001 
 
¥. Serum 25-hydroxy vitamin D < 20 ng/ml 
 
Discussion 
The results of this study indicated that normalization of 
vit D deficiency in patients with BPPV significantly reduces 
recurrent attacks. The population of this study recruited 
among patients who had recurrent BPPV and  
 The occurrence of current attacks were confirmed prior 
to inclusion.  
Data in this context are scarce and a few studies have 
addressed this issue. In a study by Talaat et al. raising serum 
25-OHD to greater than 10 ng/ml resulted in substantial 
reduction of relapse rate of BPPV attacks as compared with 
<10 ng/ml (20). Buki et al. in a study of patients with 
frequent recurrence of BPPV found lower level of 25-OHD 
as compared with the general population and 
supplementation with vit D prevented the recurrences of 
vertigo attacks (11). Vit D deficiency is highly prevalent in 
the general population as well as patients presenting to 
medical clinics (18, 21, 22). In one study of patients 
presented to E.N.T clinic, only 3 out of 86 patients who had 
presented with more throat or upper respiratory infections 
had sufficient serum vitamin D, while the rest of patients had 
deficient or insufficient serum vit D levels (22). 
  Patients with BPPV have lower bone mineral density 
than controls (13). Biochemical markers of bone turnover 
correlate with BPPV (23). In a review of 101 cases, BPPV 
was more prevalent in women at postmenopausal age 
(6).Low bone mass and bone fracture are risk factors for 
BPPV. 
 These are also prevalent in postmenopausal women due 
to reproductive and hormonal changes (24-26). Patients with 
BPPV particularly older than 65 years are at greater risk of 
fracture (27). A systematic review of seven studies 
demonstrated a positive correlation between low bone mass 
and BPPV especially in older women (28). 
Beneficial effect of raising serum vit D in this study is of 
particular importance because vit D deficiency contributes to 
the development or progression of osteoporosis and fractures 
as well as occurrence of several common clinical conditions 
which may coexist with BPPV (14, 15, 17, 18, 29, 30). Thus, 
the findings of this study highlight serum 25-OHD 
measurement in patients with BPPV particularly in patients 
who do not respond to rehabilitation therapy. Nevertheless, 
interpretation of these findings should be considered with 
caution, because the present study has several limitations.  
 Data were obtained by self-report and are particularly 
subject to bias. Information regarding several clinical 
conditions such as hypertension, hyperlipidemia and diabetes 
has not been collected. Either of these conditions may 
directly or indirectly present with manifestations simulating 
dizziness or feeling of vertigo and confound the results. 
Nonetheless, the confounding effects are expected to be 
minimal since these factors are distributed similarly across 
the two comparison groups.  
The strength of this study is dependent on the design of 
this study in which the treatment and control groups were 
followed longitudinally over six months, although the 
duration of follow-up was not long enough to generalize the 
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results. Additionally, in this study, the role of seasonal 
variations on serum 25-OHD over the study period is 
expected to be minimal because of lack of seasonal vit D 
variations in the geographic region of this study (31). 
In conclusion, this study showed that in patients with 
recurrent BPPV who are under rehabilitation therapy, raising 
serum 25-OHD to normal value reduces recurrent rate of 
BPPV significantly. These findings highlight serum 25-OHD 
measurement in BPPV. Further studies with larger sample 
size with prolonged follow-up period is required to support 
these findings. 
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